AI assistant
UPEXI, INC. — Director's Dealing 2025
Jul 30, 2025
33031_dirs_2025-07-30_cb9f9621-a543-42ed-a120-a32e65e3e93f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UPEXI, INC. (UPXI)
CIK: 0001775194
Period of Report: 2025-07-11-05:00
Reporting Person: Salkind Gene (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-11-05:00 | Common Stock | P | 20243 | $4.94 | Acquired | 385370 | Direct |
| 2025-07-16-05:00 | Common Stock | A | 50000 | — | Acquired | 435370 | Direct |
| 2025-07-16-05:00 | Common Stock | A | 150000 | — | Acquired | 585370 | Direct |
Footnotes
F1: The Reporting Person purchased these shares pursuant to a private placement offering conducted by the Issuer. The Common Stock is being offered pursuant to the exemption from registration under
Section 4(a)(2) of the Securities Act of 1933, as amended and Rule 506(b) of Regulation D promulgated thereunder, and applicable state securities laws.
F2: Vests in full 90 days from July 1, 2025.
F3: Vests quarterly in equal installments over 12 months beginning July 1, 2025.
F4: The shares of Common Stock reported herein were granted pursuant to the Issuer's Equity Incentive Plan.